HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

The effectiveness of sotrovimab vs. molnupiravir in preventing severe COVID-19 outcomes in non-hospitalized high-risk COVID-19 adult patients

Researchers compared the efficacy of sotrovimab and molnupiravir in preventing severe COVID-19 outcomes among non-hospitalized and high-risk COVID-19 patients across England.

25 May 2022

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

Three historically neglected diseases - the 'Big Three', namely tuberculosis, malaria and HIV/AIDS- could be set to benefit from the phenomenal strides that have occurred in vaccine technology in the 2020s.

11 May 2022

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

The National Institutes of Health has awarded Albert Einstein College of Medicine a five-year, $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research and expand its efforts to prevent, treat and cure HIV infection, and thereby reduce the burden of HIV, locally, nationally, and internationally.

3 May 2022

Sen. Orrin Hatch’s legacy tracks the GOP’s evolution on health

When it comes to health policy, former Utah Republican Sen. Orrin Hatch, who died April 23 at age 88, leaves a complex legacy of major legislative achievements, changing positions, compromises, and fierce opposition.

28 Apr 2022

New CDC analyses shine light on mental health of U.S. high school students during the pandemic

New CDC analyses, published today, shine additional light on the mental health of U.S. high school students during the COVID-19 pandemic, including a disproportionate level of threats that some students experienced.

12 Apr 2022

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

After the success of mRNA vaccines against COVID-19, scientists are cautiously optimistic that the same technology can be used to tackle other widespread diseases such as malaria.

7 Apr 2022

Booster doses provide strong protection against hospitalization and death from COVID-19

Booster doses of mRNA vaccines provided strong protection against hospitalization and death from COVID-19 in Qatar, though breakthrough SARS-CoV-2 infections were greater for the omicron variant compared with the delta variant, according to a study by investigators at Weill Cornell Medicine—Qatar.

30 Mar 2022

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

23 Mar 2022

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

A new highly sensitive, easy-to-use test for COVID-19 that requires a single swab and 15 minutes has received emergency use authorization (EUA) status from the U.S. Food and Drug Administration (FDA).

16 Mar 2022

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

The first 12 study participants have been enrolled in a new Phase 1 clinical trial using the messenger ribonucleic acid (mRNA) vaccine technology developed by Moderna.

14 Mar 2022

UC San Diego receives $38 million USAID grant to address gender equity and health issues

The U.S. Agency for International Development has funded a $38 million, five-year project led by the Center on Gender Equity and Health at University of California San Diego School of Medicine and Herbert Wertheim School of Public Health and Human Longevity Science.

14 Mar 2022

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched a Phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved COVID-19 vaccines.

14 Mar 2022

Charts paint a grim picture 2 years into the coronavirus pandemic

The coronavirus pandemic is now stretching into its third year, a grim milestone that calls for another look at the human toll of covid-19, and the unsteady progress in containing it.

7 Mar 2022

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Anthony Cantu, 31, counsels patients at a San Antonio health clinic about a daily pill shown to prevent HIV infection.

3 Mar 2022

Covid expert joins exodus into business, where science parlays into profits

Millions of free covid-19 rapid tests arriving in Americans' mailboxes are long-awaited vindication for Dr. Michael Mina, who, as a Harvard assistant professor, had been advocating for two years that the best way to limit covid is to identify it quickly, cheaply, and widely with rapid antigen tests so infected people know to isolate themselves.

2 Mar 2022

CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.

Despite overall progress in reducing HIV transmission in the United States, HIV continues to affect some groups more than others due to longstanding and ingrained barriers.

3 Feb 2022

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is focusing on preparing for a range of other viral threats that could cause a public health emergency.

2 Feb 2022

Researchers call for tailored public health messaging about COVID-19 vaccination for HIV patients

While most people living with HIV have received at least one dose of the COVID-19 vaccine, younger and Black individuals are hesitant to get vaccinated and have lower vaccination rates, according to a new study by Rutgers researchers.

22 Jan 2022

Study reveals how state laws affect access to HIV pre-exposure prophylaxis

State laws in the US that require medical doctors (MDs) to determine which medications a nurse practitioner (NP) or physician assistant (PA) can prescribe, and under what conditions, may limit the number of patients who use HIV pre-exposure prophylaxis (PrEP), reports a study in The Journal of the Association of Nurses in AIDS Care.

22 Jan 2022

Antimicrobial resistance causes more deaths than HIV and malaria

Antibiotic-resistant bacterial infections resulted in more than 1.2 million deaths worldwide in 2019, exceeding the number caused by HIV/AIDS and malaria, says a study spanning 204 countries and territories.

22 Jan 2022

HIV/AIDS News and Research

Further Reading

The effectiveness of sotrovimab vs. molnupiravir in preventing severe COVID-19 outcomes in non-hospitalized high-risk COVID-19 adult patients

The 'Big Three' could benefit from the phenomenal strides in vaccine technology

NIH awards $11.3 million grant to renew the Einstein-Rockefeller-CUNY Center for AIDS Research

Sen. Orrin Hatch’s legacy tracks the GOP’s evolution on health

New CDC analyses shine light on mental health of U.S. high school students during the pandemic

Scientists are searching for the ‘perfect protein’ to develop mRNA-based malaria vaccine

Booster doses provide strong protection against hospitalization and death from COVID-19

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

Highly sensitive PCR test for COVID-19 receives FDA emergency use authorization

New Phase 1 clinical trial of mRNA HIV vaccine enrolls first participant

UC San Diego receives $38 million USAID grant to address gender equity and health issues

NIH launches Phase 1 clinical trial evaluating three experimental mRNA HIV vaccines

Charts paint a grim picture 2 years into the coronavirus pandemic

HIV preventive care is supposed to be free in the US. so, why are some patients still paying?

Covid expert joins exodus into business, where science parlays into profits

CDC report underscores the need to address social determinants that contribute to HIV disparities in the U.S.

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

Researchers call for tailored public health messaging about COVID-19 vaccination for HIV patients

Study reveals how state laws affect access to HIV pre-exposure prophylaxis

Antimicrobial resistance causes more deaths than HIV and malaria

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News